The treatment of liver cancer | liver cancer treatment

Mesothelioma No Responses »
Sep 262011

Primary liver cancer is cancer that forms in tissues of the liver. Secondary liver cancer is cancer that spreads to the liver from another part of the body. The only cure for cancer of the liver is an organ transplant, "explains Zuckerman, an associate professor and interventional radiologist at UC." However, this procedure allows us to stabilize the patient 's position to control cancer growth and tumor shrinkage. Then we can deal with it surgically, or as a stand-alone therapy for patients who aren t good candidates "for surgery."

Liver Cancer Treatment

Surgery is the most effective treatment for primary liver cancer, but this is not always possible due to the size or position of the tumor. It is possible to use if the cancer has spread beyond the liver. If the liver is damaged by cirrhosis can not be safe for surgery.

Alcohol injection: In this procedure, pure alcohol is injected directly into tumors, either through the skin or during an operation. Alcohol will dry the tumor cells and eventually the cells die. Each treatment consists of an injection, although you may have a series of injections for best results. Injection of alcohol has been shown to improve survival in people with small hepatocellular tumors. Can also be used to help reduce symptoms in cases of metastatic liver cancer. The most common side effect is leakage of alcohol in the liver or abdominal cavity.

Radiofrequency ablation: In this procedure, the electric current in the radiofrequency range is used to destroy malignant cells. The use of ultrasound or CT guidance, the surgeon inserts several thin needles into small incisions in the abdomen. When the needles reach the tumor, they 're heated with an electric current, destroying the malignant cells. Radiofrequency ablation is an option for people with small tumors, unresectable hepatocellular and for some types of cancer with liver metastases. Although the procedure has a higher risk of serious complications of alcohol injection does seem to offer better results.

Chemoembolization: Chemoembolization is most beneficial for patients whose disease is confined to the liver. Has shown some success with patients whose cancer has spread to other areas. Patients with kidney disease, problems with blood clotting, or known allergies to contrast agents are not good candidates for this procedure.

Radiation therapy: This treatment uses powerful energy beams to destroy cancer cells and shrink tumors. Radiation may come from a machine outside the body or
radiation containing materials inserted into your liver. Radiation can be used in monotherapy for the treatment of localized unresectable cancer. Or you may have radiation therapy after surgical removal of a tumor to help destroy the remaining malignant cells. Radiation side effects can include fatigue, nausea and vomiting.

Chemotherapy: This treatment uses powerful drugs to kill cancer cells. Systemic chemotherapy can be "meaning that travels throughout the body in the bloodstream," or regional level.

Systemic chemotherapy is usually not effective in treating liver cancer, but may be a treatment option in some cases.

Share
Posted by mesynet at 2:54 pm Tagged with:

Liver Disease | Infusing Chemotherapy Into The Liver Gives Extra Months Of Disease-free Life ...

Mesothelioma No Responses »
Sep 262011

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients

Stockholm, Sweden: Melanoma of the eye (ocular or uveal melanoma) frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients live for a year. Now, final results from a phase III study have demonstrated that a new treatment significantly extends the time patients can live without the disease progressing.

James Pingpank, associate professor of surgery at the University of Pittsburgh Cancer Institute (Pittsburgh, USA), will tell the 2011 European Multidisciplinary Cancer Congress [1] on Saturday that, by April 2011, the length of time that patients survived without the metastases spreading further in the liver (disease progression) was an average of 8.1 months for those receiving the new treatment compared to 1.6 months in the group of patients that had been randomised to receive the best alternative care.

The new treatment is called percutaneous hepatic perfusion (PHP) and is designed to saturate the liver with high doses of chemotherapy without affecting the rest of the body. The chemotherapy drug melphalan is infused directly into the liver via an intra-arterial catheter over a period of 30 minutes. Blood in the veins leading out of the liver is then captured and filtered through a specially designed, double-balloon catheter to extract the drug before the cleaned blood is returned to the body. This enables the drug to be delivered directly to the liver to target the melanoma metastases there, but in a minimally invasive manner. The patient is monitored in intensive care before being allowed home. Once the liver has recovered from the toxicity of the treatment, the procedure is repeated every four to eight weeks.

In a phase III, randomised trial that took place in nine US clinics, 93 patients were randomised to receive PHP or best alternative care between February 2006 and July 2009. Best alternative care (BAC) was decided by the patient’s treatment team and could involve interleukin 2, ipilimumab, transcatheter arterial chemoembolisation (TACE), systemic chemotherapy or inclusion in a clinical trial.

As the study was not designed to show an overall survival benefit, and most of the patients had no other treatment options available to them, patients were allowed to cross over from the BAC arm of the study to the PHP arm once the benefits of PHP became apparent.

PHP patients had an overall progression-free survival time of 6.1 months versus 1.6 months in the BAC group. Overall survival at one year was 29% on PHP versus 26% on BAC. Due to the fact that 51% of patients crossed over from the BAC arm to the PHP arm, overall survival was not significantly different between the two groups: 11.4 months on PHP versus 9.9 months on BAC. However, those patients who did cross over seemed to do well despite being amongst the sickest, surviving for 9.2 months without the disease progressing in the liver, and 6.5 months without any overall progression of the disease.

Prof Pingpank will say: “This is the first phase III study of PHP in patients with liver-dominant metastatic melanoma and shows that PHP with melphalan significantly improves overall response rates and progression-free survival, providing a new treatment option for the disease. This report includes all data on patients who are more than one year on from inclusion in the trial and we now have all the final response rates. The only thing that may change over time is the examination of the possible long-term benefits, as all but one of the surviving patients were treated with PHP or crossed over to receive it.”

For a disease that currently has few treatment options and no chance of a cure, Prof Pingpank says PHP offers patients extra months of, usually, good quality life. Although the adverse effects of PHP were more severe than BAC, they were short-lived. “Side effects were predominantly neutropenia [low white blood cell count] and thrombocytopenia [low platelet count]. The majority of patients were able to undergo multiple treatments in the PHP arm, as toxicity resolved, whereas the major toxicity in the control arm was liver failure and/or death on treatment from disease progression,” he will say.

“This is the first treatment to show a clinical benefit in patients with liver metastases from ocular melanoma. Most patients retain 80% or more of their daily functional status, and return to full performance once therapy is completed. If subsequent recurrence is noted in the liver, retreatment is possible and effective. At this point, it appears that there are groups of patients surviving substantially longer than those control arm of the study, with good quality of liver and preservation of liver function.”

PHP potentially could be used for other cancers that have spread to the liver. “We have demonstrated efficacy in a phase II setting for patients with metastatic neuroendocrine tumours [2], so the application of this technology is likely to expand to other tumour types,” says Prof Pingpank. “In addition, we have previously demonstrated efficacy of high dose regional melphalan for patients with metastatic colorectal cancer, albeit through a different circuit.”

The device that delivers and filters the melphalan has been approved in Europe for use in all malignant liver tumours, while approval is pending in the USA for melanoma only.

Prof Pingpank will conclude: “Certainly, with 50 percent of melanoma patients with metastatic liver disease dying of liver failure, we see this as a frontline therapy for patients with this disease. There is always controversy surrounding the application of regional therapy to patients with metastatic disease, especially when there is a high risk for metastases elsewhere in the body. However, at present, the dearth of options for patients with metastatic melanoma renders this a moot point, and this therapy will be an early choice for patients with liver-only disease.”

Former president of ECCO and Director General of the Institut de Cancrologie Gustave Roussy (Paris, France), Professor Alexander Eggermont said: “The maturity of the data presented today better depicts the value as well as the limitations of percutaneous hepatic perfusion. One of the interesting points is that, in these relatively good patients, those that crossed over from the BAC arm of the study have good progression-free survival after a ‘late’ PHP that is about the same as when PHP is given upfront. In the absence of identified targets for targeted drugs in uveal melanoma, one might consider testing the role of ipilimumab following a PHP.”

ESMO spokesman, Professor Ulrich Keilholz, of the Department of Hematology and Medical Oncology and Deputy Director at the Charit Comprehensive Cancer Center, Berlin, Germany, said: “The study by Pingpank is the first phase III trial in uveal melanoma and the first trial to show a benefit of regional treatment for liver metastases in this disease. Given the current lack of targeted drugs in this disease – in contrast to the emerging treatments in cutaneous melanoma – the clinically relevant benefit achieved with melphalan perfusion provides a new reference treatment for patients with hepatic metastases of uveal melanoma.”

Abstract no: 9304. Saturday, 11.15 hrs (CEST), Melanoma and skin cancer session, Hall T1.

[1] The 2011 European Multidisciplinary Cancer Congress is the 16th congress of the European CanCer Organisation (ECCO), the 36th congress of the European Society for Medical Oncology (ESMO) and the 30th congress of European Society for Therapeutic Radiology and Oncology (ESTRO).

[2] See poster number 6621: “Percutaneous Hepatic Perfusion (PHF) with melphalan for patients with unresectable liver metastases of neuroendocrine tumours (MNET)”. Poster on Monday in poster session on Gastrointestinal Malignancies – Noncolorectal Cancer.

[3] Funding for this trial was provided by Delcath Systems Inc, New York, and the US National Cancer Institute (NCI).

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Share
Posted by mesynet at 12:24 pm Tagged with:

Liver | The Fatal opioid overdoses Waismann Method steep Medical Director warns

Mesothelioma No Responses »
Sep 262011

Study reports of new cases of overdose of painkillers, outnumber deaths from multiple myeloma, liver disease and HIV

Beverly Hills, California (PRWEB) September 13, 2011

"Unfortunately, many people have the impression that analgesics are harmless because they are prescribed by a doctor, but that isn 't always the case," said Dr. Lowenstein. "Prescription pain relievers are opioids such as heroin, and can be extremely dangerous when abused or used for a long period of time. We have seen a huge increase in opioid overdose deaths in the last decade. Not only are opioids increasingly prescribed by doctors, but the online pharmacies and "pill mills," where drugs are sold illegally in large quantities without a prescription, are increasingly common around the country. "

Researchers from the British Medical Journal found that between 1999 and 2007, the number of deaths related to opioids, which are relatively young and mostly unintentional or accidental, increased from 4041 to 14,459. The report indicates that young adults have taken a seemingly carefree attitude towards prescriptions and do not recognize the extreme dangers of recreational with prescription pills. In fact, a study funded by the National Institutes of Health found that eight percent of the nation 's 12th-graders have abused hydrocodone in the past year.

In Florida, where many of the mills of the nation "s illegal pill is found, the local government officials have been trying to enact stricter laws to close the factories of the pill. According to the New York Times, new laws also limit or prohibit the majority of Florida's medical prescription and sale of prescription painkillers in their offices or clinics. Because this new law, the purchase of oxycodone was reduced by 97 percent since last year, which in its height reached 32.2 million doses sold in the first six months of 2010.

The Waismann Method is a proven, safe treatment for opiate dependence, which uses the most advanced techniques of medicine. The rapid detoxification procedure for opiate takes place in a full-service hospital in southern California board-certified anesthesiologists, while patients remain under deep sedation, so the least conscious experience of pain or withdrawal. After medical treatment, patients are taken to Domus Retreat for an evaluation to determine the underlying causes of dependency, and a personalized aftercare plan is assigned to ensure a healthy and effective transition to life without opiates. The Waismann Method patients achieving an extremely high success rate because they no longer fight the constant physical cravings for opiates that have led to relapse in the past.

For more information about the Waismann Method opiates.com visit. For interviews contact at 858-888-0149 or Nicolette Surh send an email to Nicolette (a) rkpr? (Dot) net.

About the Waismann Method

Performed in a hospital intensive care unit, the Waismann Method involves cleansing receptors in the brain of a patient 's drug, while the patient is under deep sedation, reversing the chemical imbalance. During the procedure, the patient will experience minimal conscious withdrawal, and will be able to return home within days. One hundred seventy-five patients dependent on prescription drugs that are treated with the Waismann Method remain drug free after one year. Please visit opiates.com for more information.

Nicolette Surh
RKPR
(858) 888-0149
Email Info

Share
Posted by mesynet at 9:05 am Tagged with:

The symptoms of lung cancer | Small cell lung cancer

Mesothelioma No Responses »
Sep 262011

In addition, loss of appetite, loss of fatigue, unusual weight loss are three symptoms that are indicative of lung cancer.

Lung Cancer Treatment Small Cell

Because of the nonspecific nature of the symptoms of mesothelioma, mesothelioma tests are essential to rule out incidence of the disease when lung cancer symptoms occur. Early detection of Mesothelioma cancer substantiated by clear information of patient exposure 's to asbestos can help define the course of treatment.

Early detection of mesothelioma cancer in predicting long-term health

The time between exposure to asbestos and the onset of the symptoms of lung cancer can be between 15-50 years. Therefore a complete medical history and information of possible asbestos exposure are critical in identifying patients who are prone to develop lung cancer mesothelioma.

During physical tests for lung cancer mesothelioma, the doctor can check breath sounds to see if there is any indication of fluid in the chest cavity. A variety of diagnostic procedures also help determine if a patient has lung cancer mesothelioma.

The results of imaging tests, biopsies, pulmonary function tests and other diagnostic techniques, together with the results of a careful medical history help to define the course of treatment for lung cancer mesothelioma.

Secrets Revealed lung cancer or lung cancer mesothelioma Such patients may have symptoms like a hoarse voice, difficulty swallowing, swelling of the face or neck, pain or discomfort in the ribs, and shortness of breath caused by fluid in the lungs.

If you suspect you or a family member has symptoms of lung cancer "NO DELAY" consult your doctor immediately.

Advances in the treatment of lung cancer Click here

Share
Posted by mesynet at 5:45 am Tagged with:

Treatments for lung cancer | ANN ARBOR: Hundreds Attend University of Michigan Vada Murray Cancer fundraiser (with video)

Mesothelioma No Responses »
Sep 262011

By Michelle Pafford Helms, special writer

The event included a silent auction, held at the University of Michigan 's Northern Research Grants Campus complex and has generated for the Vada Murray Fund for Cancer Research.

Vada Murray is a name well known in the area as it was a defensive back Bo Schembechler 's Michigan Wolverines from 1986 to 1990 and played in three Rose Bowl during his time at U of M. He was also a police officer for the city of Ann Arbor for 21 years.

According to many, however, Murray was best known as an extraordinary human being who lost her battle with lung cancer last April, leaving behind his wife, Sarah, son, Deric, 12, and her daughters , Kendall, 9, and Harper, 6.

The former U of M and All-American Welborn Tripp attended the one day event and signed autographs as a way to show your support.

"This is a wonderful event for the wonderful family," Welborn said. "I feel blessed to be part of it."

Sarah Murray said that in establishing the fund was a way for her to engage children and to fund research into treatments for early detection of lung cancer, the causes of the disease (with a focus on environmental causes) and treatments cancer.

"The bottom line is the genesis of me still feels as if to defend himself. It 'sa way for me to honor him and his fight against disease," said Murray. "They have made great strides in cancer treatments and screening strategies, but I feel I know first hand is not enough."

Dr. Gregory Kalemkerian, the oncologist at the U of M, Murray is said that the amount of research funding for lung cancer is very low. The disease, which 200,000 people are diagnosed each year in the United States, the death of approximately 150,000 to 160,000 a year.

"Vada lived three times longer than the average person with lung cancer stage 4," said Kalemkerian. "The will to live had Vada was phenomenal."

Murray said Kalemkerian benefited by participating in a clinical trial through the Karmanos Cancer Center, which allowed him to test the new drug approved by the FDA or medically known as crizotinib Xalkori.

While grateful that the drug extended her husband 's life in an estimated six to eight months, Murray said he still was not' t long enough.

"Eight months? He was 43 years," he said. "I was thinking, our youngest son is 6, how about eight?

"Vada just wanted to be home with her children and me. Thus, we have spent the last two and a half years trying very hard to maintain our normal life. Driving to our children to football matches? Go to school functions , go to Michigan games and do what you normally do. "

While Murray was a non-smoker, his wife said he would prefer not to dwell on that point, but rather talks about the critical need of funding for cancer research.

"Cancer is a disease that doesn 't discriminate. It can strike if you smoke or do not' t smoke. Doesn 't care. It affects men and women and children of all ages," said Murray. "The fund will support all types of cancer, period. I feel that is all tied together."

Move forward with their efforts, Murray said he used the day 's fundraising as a platform to thank friends, family and colleagues, but also as a way of asking for more help for your family' s the cause in which each dollar donated will go to cancer research at the U of M.

"The whole community for two years and a half years wrapping his arms around us, and they only suspended in the wings, eager to help, wanting to do something for us," said Murray. "I want to go back to the community and say," I know he wanted help before – it was not 't anything I could have asked you to do -. But now there is ""

For more information about contributions to the Fund Vada Murray, vadamurray@gmail.com e-mail, or visit www.vadamurray.com. A gift to the fund can be made by contacting the U of M 's Office of the Internal Medicine Department of Development, 1000 Oakbrook Drive, Suite 100, Ann Arbor, MI 48104, or by calling 1-866-860 – 0026.

Return to paging

Share
Posted by mesynet at 2:48 am Tagged with:

Lung Cancer Treatment | Men's Health: Lung Cancer Is Oft-Veiled Killer

Mesothelioma No Responses »
Sep 252011

Far less is heard about lung cancer, but it kills more men each year in the United States than any other cancer.

The American Cancer Society estimates 156,940 people will die this year from cancers of the lung and bronchus – approximately 85,600 men and 71,340 women.

Not only does lung cancer affect a significant portion of the population in the United states, it is also a very unrelenting disease.

“With lung cancer, the survival rate is not as high,” said Robin Stewart, manager of clinical research at Lakeland Regional Cancer Center. “There’s a lot of research going on with lung cancer, but it’s not a disease with survivors pushing for a lot more things.”

Stewart and Dr. Fred Schreiber, a veteran Watson Clinic oncologist, agree on the chief cause of lung cancer and the best prevention.

“The best policy is avoid it, which means don’t smoke,” Schreiber said. “It’s a deadly cancer because it’s usually found in an advanced stage rather than early.”

Lung cancer tends to be faster growing and more prone to spread than prostate cancer, Schreiber said,

That explains in part why lung cancer isn’t detected until the later stages for many patients, said Stewart, an oncology nurse with a doctorate in human services.

Another reason is that people are in denial about their risk of getting lung cancer, said Noreen McGowan, a registered nurse who heads Watson Clinic‘s clinical trials programs.

They advocate abstaining from smoking and said for people who do smoke, quitting is the best deterrent.

Those who won’t quit or feel they can’t quit should, at minimum, avoid smoking in enclosed spaces where they will get exposed to both first- and second-hand smoke, Stewart said.

Persistent coughing, shortness of breath and changes in a person’s type of coughing can be symptoms of lung cancer, they said, although those can signal other illnesses as well.

Clinical trials involving various combinations of drugs for lung-cancer treatment take place at both Lakeland cancer centers: LRCC, which has cancer doctors employed by Lakeland Regional Medical Center; and Center for Cancer Care and Research, which has cancer doctors from Watson Clinic and Clark and Daughtrey Medical Group.

Trials often involve combinations of standard chemotherapy and new experimental drugs.

The only trial current enrolling new patients at LRCC pairs an unnamed experimental drug with the now-standard combination of carboplatin, paclitaxel and bevacizumab, Stewart said. It’s for patients with non-small cell lung cancer. Small cell lung cancer is a fast-growing type of lung cancer that spreads much more quickly than non-small cell lung cancer.

Bevacizumab was approved as part of lung-cancer treatment during the past three years, Stewart said, after having been tested in earlier clinical trials.

The experimental drug in LRCC‘s still-enrolling clinical trial is targeted therapy, which increasingly is being used in additional to standard chemotherapy.

“Targeted therapy is the wave of the future,” Schreiber said. “We have several (cancer trials) going on involving targeted therapy.”

Targeted drugs are designed to go straight to receptor sites on cancer cells, as opposed to traditional chemotherapy that destroys all rapidly dividing cells, Stewart said.

Eclipse, one of two lung-cancer trials enrolling new patients at the Center for Cancer Care and Research, uses targeted therapy. It’s for some squamous non-small-cell lung cancer patients who are at stage IV, when the cancer is the most extensive, McGowan said.

While hopeful about targeted therapy, Schreiber said he doesn’t want anyone thinking its development changes the realities of lung cancer.

“Therapies are slowly getting better, but avoiding lung cancer is a smarter policy than thinking you can be (successfully) treated,” he said.

The status of lung-cancer patients sought for Center for Cancer Care and Research trials bears that out. Along with the stage IV patients treated in its Eclipse study, there’s another drug combination trial for “poor performance status” patients with advanced non small-cell lung cancer.

A trial that recently closed for enrollment there had sought patients with “extensive stage’ small cell lung cancer.

[Robin Williams Adams can be reached at robin.adams@theledger.com or 863-802-7558. Read her blog at robinsrx.blogs.theledger.com. Follow on Twitter at ledgerROBIN.]

Share
Posted by mesynet at 8:52 pm Tagged with:

Liver Cancer | Mother And Son's Day Out Focuses On Fair, Not Health Issues

Mesothelioma No Responses »
Sep 252011

Friday was a mom and son day at the Panhandle-South Plains Fair.

“She’s 87, and I’ve been battling liver cancer for nearly a year, and I just decided that me and Mom were just going to go to the fair,” Jay Green said.

“With my condition, as we all know, only God knows how much time we all have. And Mother, being her age, and with my condition, each day’s a gift. This day could pass us by, and we would never have the opportunity to get to share a moment like this again.”

Frances Green, who hadn’t been to the fair in 20 years, was ready to try it. If her son could push her wheelchair, and the macular degeneration in her right eye would allow, they would see the fair ” and ride the Ferris wheel, too.

The Ferris wheel looked really high, higher than even Jay remembered. “Are those buckets up there?” he asked. “I don’t remember them looking like that. That’s the highest ride out here.”

Nevermind the height for now. Frances, with her wheelchair powered by her son, went looking into the animal barn, saw some booths and cast a quick glance sideways at the midway where that high Ferris wheel was waiting.

They found Jay’s sister, Beverly Odell, and family friend Michelle Parrish in the vendor area. It would soon be time to stop for lunch, too.

Frances said, “We’ve circled around, and we’ve seen all of these booths and everything, so we will ride the Ferris wheel … and it scares me.”

The mother and son have an upbeat sense of humor. “I’m a hugger, and he is too,” Frances said with a big smile.

But there’s a serious side to their lives, also, and tears can come as quickly as the smile. Four years ago, Frances lost her husband ” Jay’s father ” to cancer.

When Jay was diagnosed with liver cancer, he was told that without treatment, he could expect to live between 60 and 90 days, and that the condition was considered terminal.

His treatment has included radiation and chemotherapy.

Although he still works as many days a month as he can as a manager at La-Z-Boy Furniture, there haven’t been a lot of strong days since.

While dealing with his own medical condition, though, Jay has found a ministry of encouragement to others.

“Covenant has been going through several different types of treatment and things like that,” he said.

“The Holy Spirit wanted me to go see children with cancer, and I didn’t want to do that … I fought that battle for several weeks before I finally started doing that.

“One 6-year-old boy who had leukemia went riding with me on my motorcycle.”

Jay said, “I had no business buying a Harley. But when I got it, I didn’t know that this 6-year-old was going to go riding on it. That’s connecting with a child.”

When he was taken into the hospital, the ministry grew into one of encouraging adults.

“All I do is go up there and share my strength and faith and everything that has been given to me, and try to pass it along to the person in the hospital room. I just try to lift them up.

“It’s been a wonderful ministry that the Lord has blessed me with, and it has blessed me as well. I come out pretty encouraged myself when I leave there. Covenant has not only taken care of me as a patient, but also has allowed me to be a volunteer and share what their hospital does.”

At the fair on Friday, lunch was over, and it was time for their date with the Ferris wheel. First a long line at the ticket booth, then that last long mile to the ride.

But what does that sign say? It says “Temporarily closed.”

The operator explains that a gear has to be replaced, and it is being shipped in ” probably it won’t be operating until late in the afternoon.

Jay went looking for a substitute ride, something that would be a bit milder. They chose the Spider.

It takes you up in a bucket and spins you around. They were enjoying the ride, even though it would be nice if it could go a little faster. And then suddenly it did go faster ” a lot faster.

“Get me off; I’m getting sick,” Frances confided to Jay.

When they stopped, the operator asked to have his picture made with Frances, who he said now holds the record for age on his ride.

“It was more challenging than the Ferris wheel would have been,” Jay said.

But they had done the fair and its midway all in one day. They made their way to Jay’s vehicle for a trip home with unfading memories.

And the smiles were back again.

Frances noted she regularly attends Trinity Church. “We hug over there ” I like that.”

Jay, who attends Victory Life Baptist, plans to go back to work and also continue his newfound ministry:

“God gave me the opportunity to share his work. Out of 51 years ” and I have had this for almost 15 months ” other than the chemo and the bad feeling, these past 14 months have been the best time of my life.”

To comment on this story:

ray.westbrook@lubbockonline.com 766-8711

leesha.faulkner@lubbockonline.com 766-8706

Share
Posted by mesynet at 6:28 pm Tagged with:

Multiple Sclerosis Treatment | The variety of MS symptoms

Mesothelioma No Responses »
Sep 252011

Multiple sclerosis is a disorder very interesting CNS (central nervous system), covering multiple patterns of progression. While people with multiple sclerosis can be perceived slow progress of low intensity symptoms or no symptoms at all, people with rapidly progressing forms of the disease could be confronted with very severe symptoms and may be at risk of developing serious complications threatening.

Due to the fact that multiple sclerosis primarily affects the central nervous system, the first symptoms experienced by patients are of a sensory or cognitive. Some of the first symptoms that occur in people with multiple sclerosis are decreased visual acuity, blurred vision, double vision or difficulty distinguishing colors. In addition, the tissues around the eye can become inflamed and painful, some patients may experience severe pain and discomfort when moving the eyes.

Most of these symptoms occur due to optic neuritis condition, often associated with multiple sclerosis. When the condition is discovered and appropriate patients receive proper medical treatment, the majority of visual symptoms can be completely removed within weeks. However, in the absence of medical treatment, patients may remain with permanent visual defects. In some cases, unattended visual symptoms of multiple sclerosis may even lead to permanent blindness.

When multiple sclerosis affects the cerebellum (the part of the brain responsible for motor function and balance), the results are poorly coordinated movements and difficulty maintaining balance. Sometimes, patients may experience difficulty walking and a variety of activities that require precise movements, properly coordinated.

When it affects other areas of the brain, multiple sclerosis can cause symptoms such as hearing loss, dizziness and vertigo. Multiple sclerosis patients may also suffer from impaired judgment, inability to concentrate, short term memory loss, mental confusion and difficulty pronounced expressed in speech.

Symptoms as muscle weakness, numbness and pain as well as decreased or increased sensitivity to stimuli of heat or light are possible signs of multiple sclerosis has also reached the peripheral regions of the nervous system. At this stage, patients may also suffer from dysfunction of the bladder or the kidney, liver dysfunction and disorders of the gastrointestinal tract. Internal organs like the liver, lungs and heart may also be involved in the advanced stages of multiple sclerosis.

Share
Posted by mesynet at 3:40 pm Tagged with: ,

Natural Treatments Cancer | Is it natural, alternative cancer treatment work?

Mesothelioma No Responses »
Sep 252011

I felt that if I looked hard enough, I 'd find the missing links, miracles, neighbors, plants and herbs that nature provides to help us heal. I cross the activation sources of information and crashed across the alternative cancer treatment I could find. Even the use of a team of researchers to gather information with me. We came up with 350 natural cancer treatments, surprising even ourselves. It is the most comprehensive collection found anywhere in the world today.

Each of the 350 alternative treatments gave us an 'Aha! "Moment, as I'm sure you. Whether you 're looking to find more information about alternative cancer treatment itself, or on behalf of a loved one, my comprehensive guide has been designed to meet your search responses.

I know how you feel helpless, not knowing what the future holds. I had so many questions. As I searched for information on conventional treatments for cancer and naturally, I was surprised to find how many alternative cancer treatments had lost public knowledge, or discredited, or forced into hiding.

You must make your own decision about the natural treatment of cancer, but I sincerely desire to own their own health and not hand it over to someone else than their own. No one on earth with more interest in your welfare than you. You must take control of their own destiny and not let others have their own interests!

The creators of these gentle and non-toxic treatments are respected Nobel Prize winners, doctors, biochemists, scientists and Ph.D. 's pre-eminent in its field. In fact, Nobel Prize winner Dr. Albert Schweizer called Dr. Max Gerson, who created a very successful nutritional therapy "a medical genius who walked among us."

Your doctor may not be aware of these treatments because he or she can only prescribe and is knowledgeable about the treatments that are regulated by the FDA … many of these herbal treatments and vitamins are outside the jurisdiction of the FDA. Natural treatments of cancer is a collection of over 350 natural cancer treatments and alternatives. The more than 80% of oncologists surveyed said they would refuse chemotherapy if they had cancer surely want the benefits of these treatments for themselves and their families. And now you know the secrets too … page after page of insightful information that can and should talk to your doctor. Self-treatment is not recommended though.

Most natural and alternative treatments are considered nonspecific. In other words, working with any type of cancer.

How successful are the conventional treatments for cancer? is an analysis of the conventional treatments are based on scientific studies, and more! Before surgery, radiation or chemotherapy. Be fully informed before consenting to treatment!

Currently, the percentage of Americans who die of cancer is almost the same as it was in 1950, even after adjustment for age. However, the medical profession has much pride in rigorous scientific research behind its approach to cancer treatment.

So in short, is there a conspiracy? As many people believe that is being driven by money! The money for big pharma? Learn, do your research and ask questions.

Investigate the possibility of natural cancer treatments and alternatives.

Share
Posted by mesynet at 12:30 pm Tagged with:

Clinical depression | Clinical depression "A chemical imbalance

Mesothelioma No Responses »
Sep 252011

Stress can be a primary indicator of depression. When dealing with long-term stress, your body can make the neurotransmitter known as serotonin and noradrenaline in the central nervous system and brain to lead to excessive workload resulting in a malfunction. Your body needs these neurotransmitters that work well to create the chemicals you need to feel happy and well. They also help control stress levels and moods in general.

Chemical imbalance caused by stress is very common. Think about it, we all worry at some time or another of a child, a friend, our personal health, work, financial problems or relationship. We can also meet to worry about the recent death of a friend or relative, or may even have recently experienced a traumatic event. Regardless of the cause, stress can lead to an imbalance of the "feel good" workers in the brain and nervous system.

The problem arises when serotonin and norepinephrine, neurotransmitters, malfunction, or even begin to creep into his normally stellar performance, it is possible that affected his mood. Things that did not bother you now may seem like the end of the world and your feelings may seem totally out of control and you may find yourself struggling with depression.

In the face of a blown battle with clinical depression, people who suffer often face both physical and mental challenges. Negative thoughts can invade the mind totally distort the reality of a situation. This can cause serious problems because when the distortion of thinking associated with depression can lead to behavior change, thus altering their lives.

Clinical depression can certainly make you change your behavior and daily activities. It can make you stay away from family and friends can make you want to stay home under the covers languishing in the safety of his bed, which can cause physical pain, you can banish your appetite and may even cause suffering from reduced sexual behavior.

How to overcome the demons of clinical depression? First find medical care a qualified health professional who can help you get the treatment you need. Dealing with the pain of depression is the best decision you can make. Avoiding treatment is wrong, and unless someone intervenes cares about you and helps you realize you need help, then avoid the treatment can be a fatal mistake, because there are times when depression can spiral out of control that can lead to suicide.

After taking the decision to seek medical care for the treatment of depression after the first thing to recognize is the value that was for you to seek help.

Then you should be actively involved in treatment that can fight against the demons of depression trying to overcome his life. Depression can be a hereditary condition and can also be cyclical, which means they can come and go throughout his life.

Treatment often takes several weeks and sometimes months, even to be a success. However, a combination of counseling and medications designed to treat depression have proven more successful.

Seek medical attention if you are suffering from clinical depression is the greatest gift of all that I could ever give yourself or your family. Find the help you need and keep fighting. Your life and your happiness is worth the effort.

Share
Posted by mesynet at 9:02 am Tagged with:
Older Entries
© 2011 Mesothelioma Symptoms Treatment Suffusion theme by Sayontan Sinha